Location History:
- Retie, BE (2014)
- Beerse, BE (2019)
Company Filing History:
Years Active: 2014-2019
Title: Innovations by Inventor Ruben De Keyser
Introduction
Ruben De Keyser is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of crystallization processes, particularly in the pharmaceutical industry. With a total of 2 patents, his work focuses on improving the properties of various compounds.
Latest Patents
One of his latest patents is titled "Crystallization procedure for obtaining canagliflozin hemihydrate crystals." This invention relates to an improved crystallization procedure that allows for the production of canagliflozin hemihydrate crystals with a narrow particle size distribution. The process involves removing a small part of the crystalline suspension from the crystallization vessel, subjecting it to particle size reduction, and then reintroducing it into the vessel while maintaining a specific temperature range.
Another significant patent by De Keyser is the "Crystallisation process for 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl] benzene." This invention aims to obtain hemihydrate crystals of the compound with improved flowability, bulk density, and tap density properties.
Career Highlights
Ruben De Keyser is currently employed at Janssen Pharmaceutica NV, a leading company in the pharmaceutical sector. His work at Janssen has allowed him to focus on innovative crystallization techniques that enhance the quality and efficiency of drug development.
Collaborations
Throughout his career, De Keyser has collaborated with several professionals, including Thomas Joachim Landewald Rammeloo and Stijn Laps. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Ruben De Keyser's contributions to the field of crystallization in pharmaceuticals highlight his innovative spirit and dedication to improving drug formulation processes. His patents reflect a commitment to enhancing the quality of pharmaceutical compounds, making a significant impact in the industry.